Speaker: Piet van der Graaf, PharmD, PhD – Certara
###Speaker: Vincent Hurez, DVM, PhD (he/him/his) – Regeneron Pharmaceuticals Inc.
### he/him/hisSpeaker: Jane PF Bai, PhD (she/her/hers) – Center for Drug Evaluation and Research, US Food and Drug Administration
### she/her/hersSpeaker: Rajat Desikan, PhD (he/him/his) – Clinical Pharmacology Modelling & Simulation – Vaccines & Infectious Diseases, Precision Medicine, GSK
### he/him/hisSpeaker: Wei Gao, PhD – Moderna
### @@@ Nahor Haddish-Berhane ### 2407516###Speaker#########Speaker: Nahor Haddish-Berhane
###Co-Chair: Joy C. Hsu, PhD – Genentech
### @@@ Mark Lovern, PhD (he/him/his) – InSilicoTrials ### 2343536###Co-Chair###Chief Platform Officer###InSilicoTrials###Co-Chair: Mark Lovern, PhD (he/him/his) – InSilicoTrials
### he/him/hisChair: Lora Hamuro
### @@@ Stephen Greene ### 2501749###Chair#########Chair: Stephen Greene
### @@@ Hao Zhu, PhD – ISoP ### 2360688###Panelist###ISoP Board Member###ISoP###Panelist: Hao Zhu, PhD – ISoP
### @@@ C.J. Musante, PhD – Pfizer ### 2407910###Panelist###VP & Global Head of Pharmacometrics & Systems Pharmacology###Pfizer###Panelist: C.J. Musante, PhD – Pfizer
### @@@ Mark Dresser (he/him/his) – Gilead Sciences ### 2501751###Panelist###Senior Vice President###Gilead Sciences###Panelist: Mark Dresser (he/him/his) – Gilead Sciences
### he/him/his @@@ Liang Zhao, PhD (he/him/his) – Department of Bioengineering and Therapeutic Sciences, School of Pharmacy, UCSF ### 2360729###Panelist###Professor###Department of Bioengineering and Therapeutic Sciences, School of Pharmacy, UCSF###Panelist: Liang Zhao, PhD (he/him/his) – Department of Bioengineering and Therapeutic Sciences, School of Pharmacy, UCSF
### he/him/hisSpeaker: Liang Zhao, PhD (he/him/his) – Department of Bioengineering and Therapeutic Sciences, School of Pharmacy, UCSF
### he/him/hisSpeaker: Jenny Chien, PhD – Eli Lilly and Company
###Chair: Jingqi Gong, PhD (she/her/hers) – GlaxoSmithKline
### she/her/hers @@@ Richard Allen, PhD – Pfizer ### 2360668###Speaker###Research Fellow and Quantitative Systems Pharmacology Lead###Pfizer###Speaker: Richard Allen, PhD – Pfizer
### @@@ Oleg Demin Jr (he/him/his) – InSysBio CY ### 2360667###Both###Scientific Director, Oncology & Immuno-Oncology Quantitative Systems Pharmacology###InSysBio CY###Both: Oleg Demin Jr (he/him/his) – InSysBio CY
### he/him/his @@@ Susana Zaph, PhD (she/her/hers) – Sanofi ### 2360669###Speaker###Senior Director & Head of Translational Disease Modeling - US###Sanofi###Speaker: Susana Zaph, PhD (she/her/hers) – Sanofi
### she/her/hersSpeaker: Tawanda Gumbo, MD (he/him/his) – CEO, Phase Advance AI
### he/him/hisSpeaker: Aleksandra Galetin, PhD (she/her/hers) – University of Manchester
### she/her/hersSpeaker: Aleksandra Galetin, PhD (she/her/hers) – University of Manchester
### she/her/hersSpeaker: Samira Khalili (she/her/hers) – Ionis
### she/her/hersSpeaker: Nastya Kassir, PharmD, PhD, FCP (she/her/hers) – Genentech
### she/her/hersSpeaker: Wilhelmus E.A. De Witte, PhD – ESQlabs
### @@@ Alexander Kulesza, PhD (he/him/his) – Systems Pharmacology Lead ### 2343520###Speaker###Principal Scientist###Systems Pharmacology Lead###Speaker: Alexander Kulesza, PhD (he/him/his) – Systems Pharmacology Lead
### he/him/hisSpeaker: Alexander Kulesza, PhD (he/him/his) – Systems Pharmacology Lead
### he/him/hisSpeaker: Stephan Schmidt, PhD (he/him/his) – University of Florida, Department of Pharmaceutics, Center for Pharmacometrics and Systems Pharmacology
### he/him/hisSpeaker: Joy C. Hsu, PhD – Genentech
###Speaker: Catriona Waitt, MBChB, PhD – University of Liverpool, UK and Infectious Diseases Institute, Makerere University, Uganda
###Speaker: Grace V. Lee, PhD (she/her/hers) – Critical Path Institute
### she/her/hersChair and Speaker: ENOCH COBBINA (he/him/his) – Syndax Pharmaceuticals
### he/him/his @@@ Paolo Vicini, PhD, MBA (he/him/his) – Confo Therapeutics ### 2474036###Speaker###Chief Development Officer###Confo Therapeutics###Speaker: Paolo Vicini, PhD, MBA (he/him/his) – Confo Therapeutics
### he/him/hisModerator: Mark Lovern, PhD (he/him/his) – InSilicoTrials
### he/him/his @@@ Jared Weddell, PhD – Astellas ### 2363735###Speaker###Modeling and Simulation Scientist###Astellas###Speaker: Jared Weddell, PhD – Astellas
### @@@ Hardik Mody, PhD (he/him/his) – Genentech ### 2363736###Speaker###Principal Scientist, Clinical Pharmacology###Genentech###Speaker: Hardik Mody, PhD (he/him/his) – Genentech
### he/him/his @@@ Ahmed Abdelhady Abozeid, PhD (he/him/his) – Intellia ### 2407052###Speaker###Clinical Pharmacology Director###Intellia###Speaker: Ahmed Abdelhady Abozeid, PhD (he/him/his) – Intellia
### he/him/hisChair: Martin Bergstrand, PhD, ISOP member (he/him/his) – Pharmetheus AB
### he/him/his @@@ Pavan Vaddady, PhD – Merck & Co., Inc. ### 2360679###Chair###Executive Director, QP2 Oncology###Merck & Co., Inc.###Chair: Pavan Vaddady, PhD – Merck & Co., Inc.
### @@@ Tushar Garimella, PhD, ISoP member, ACCP member (he/him/his) – Daiichi Sankyo Inc ### 2360681###Speaker###Executive Director, Quantitative Clinical Pharmacology###Daiichi Sankyo Inc###Speaker: Tushar Garimella, PhD, ISoP member, ACCP member (he/him/his) – Daiichi Sankyo Inc
### he/him/his @@@ Andrew C. Hooker, PhD, ISOP member – Uppsala University ### 2360680###Speaker###Professor of Pharmacometrics###Uppsala University###Speaker: Andrew C. Hooker, PhD, ISOP member – Uppsala University
### @@@ Antoine Pitoy, PhD student – INSERM / Université Paris Cité ### 2408243###Speaker###PhD Student###INSERM / Université Paris Cité ###Speaker: Antoine Pitoy, PhD student – INSERM / Université Paris Cité
###Speaker: Niklas Korsbo, Ph.D. (he/him/his) – DeepPumas, Pumas-AI Inc.
### he/him/hisSpeaker: Kapil Gadkar, PhD – Genentech
###Chair: Jin Dong, PhD – AstraZeneca
###Chair: David C. Turner, PhD – Genentech
### @@@ Mitch Phelps, PhD (he/him/his) – The Ohio State University ### 2360708###Speaker###Professor, College of Pharmacy###The Ohio State University###Speaker: Mitch Phelps, PhD (he/him/his) – The Ohio State University
### he/him/his @@@ Yulia Vugmeyster, PhD – Mural Oncology ### 2360706###Chair and Speaker###Executive Director, Clinical Pharmacology###Mural Oncology###Chair and Speaker: Yulia Vugmeyster, PhD – Mural Oncology
### @@@ Youwei Bi, PhD – FDA, MD ### 2489375###Speaker###Team Lead###FDA, MD###Speaker: Youwei Bi, PhD – FDA, MD
### @@@ Da Zhang ### 2514036###Speaker#########Speaker: Da Zhang
###Chair and Speaker: Sean Hayes, PhD – Merck Research Laboratories
### @@@ Omid Bazgir, PhD (he/him/his) – Genentech Inc. ### 2360752###Speaker###Senior AI Scientist, Clinical Pharmacology M&S###Genentech Inc.###Speaker: Omid Bazgir, PhD (he/him/his) – Genentech Inc.
### he/him/his @@@ Louis Joslyn, PhD – Preclinical and Translational Pharmacokinetics/Pharmacodynamics, Genentech ### 2453718###Speaker###Principal Scientist###Preclinical and Translational Pharmacokinetics/Pharmacodynamics, Genentech###Speaker: Louis Joslyn, PhD – Preclinical and Translational Pharmacokinetics/Pharmacodynamics, Genentech
###Speaker: Jeffrey West, PhD – H. Lee Moffitt Cancer Center & Research Institute
###Speaker: Jin Niu, PhD (she/her/hers) – J&J
### she/her/hersSpeaker: Andrew C. Hooker, PhD, ISOP member – Uppsala University
###Speaker: ENOCH COBBINA (he/him/his) – Syndax Pharmaceuticals
### he/him/hisSpeaker: Richard Allen, PhD – Pfizer
###Speaker: Amitava Mitra, PhD – Clinical Pharmacology
###Speaker: Rudy Gunawan, PhD – Pfizer
###Speaker: Tushar Garimella, PhD, ISoP member, ACCP member (he/him/his) – Daiichi Sankyo Inc
### he/him/hisSpeaker: Birgit Schoeberl, PhD – Novartis
###Speaker: Bill Gillespie
### @@@ Tim Waterhouse, PhD (he/him/his) – Metrum Research Group ### 2343522###Speaker###Group Leader Statistics, Principal Scientist II###Metrum Research Group###Speaker: Tim Waterhouse, PhD (he/him/his) – Metrum Research Group
### he/him/his @@@ Curtis Johnston, PharmD – Metrum Research Group ### 2343523###Speaker###Group Leader, Principal Scientist II, PKPD M&S###Metrum Research Group###Speaker: Curtis Johnston, PharmD – Metrum Research Group
### @@@ Seth Green ### 2343524###Speaker#########Speaker: Seth Green
### METRUM002Speaker: Bill Gillespie
### @@@ Tim Waterhouse, PhD (he/him/his) – Metrum Research Group ### 2343522###Speaker###Group Leader Statistics, Principal Scientist II###Metrum Research Group###Speaker: Tim Waterhouse, PhD (he/him/his) – Metrum Research Group
### he/him/his @@@ Curtis Johnston, PharmD – Metrum Research Group ### 2343523###Speaker###Group Leader, Principal Scientist II, PKPD M&S###Metrum Research Group###Speaker: Curtis Johnston, PharmD – Metrum Research Group
### @@@ Seth Green ### 2343524###Speaker#########Speaker: Seth Green
### METRUM001Chair: Jing Su, MS – Merck & Co., Inc.
### @@@ Neelima Thanneer, MS – BMS ### 2360663###Both###Executive Director, Head of Data Science and Clin Pharm Analysis & Reporting###BMS###Both: Neelima Thanneer, MS – BMS
###Moderator: Joy C. Hsu, PhD – Genentech
### @@@ Samira Khalili (she/her/hers) – Ionis ### 2363741###Speaker###Director of Pharmacokinetics and Clinical Pharmacology###Ionis###Speaker: Samira Khalili (she/her/hers) – Ionis
### she/her/hers @@@ Donghua Yin, PhD – Pfizer ### 2363742###Speaker###Vice President, Head of Clinical Pharmacology, Pfizer Oncology Division###Pfizer###Speaker: Donghua Yin, PhD – Pfizer
### @@@ Eric Masson, PharmD – Arvinas ### 2363743###Speaker###SVP, Early Clinical Development###Arvinas###Speaker: Eric Masson, PharmD – Arvinas
###Chair: Julie A. Stone, PhD – Merck & Co., Inc.
### @@@ Youfang Cao, PhD – Eisai, Inc ### 2360717###Chair###Director of Pharmacometrics###Eisai, Inc###Chair: Youfang Cao, PhD – Eisai, Inc
### @@@ Brian A. Willis, PhD (he/him/his) – Biogen ### 2360718###Speaker and Panelist###Head of Pharmacometrics###Biogen###Speaker and Panelist: Brian A. Willis, PhD (he/him/his) – Biogen
### he/him/his @@@ Ivelina Gueorguieva, PhD (she/her/hers) – Eli Lilly and Company ### 2360719###Speaker and Panelist###Sr Director, Global PK/PD and Pharmacometrics###Eli Lilly and Company###Speaker and Panelist: Ivelina Gueorguieva, PhD (she/her/hers) – Eli Lilly and Company
### she/her/hers @@@ Seth Robey, PhD (he/him/his) – Merck & Co., Inc. ### 2360720###Speaker and Panelist###Director, Quant. Pharmacology & Pharmacometrics###Merck & Co., Inc.###Speaker and Panelist: Seth Robey, PhD (he/him/his) – Merck & Co., Inc.
### he/him/his @@@ Stephen Duffull, PhD (he/him/his) – Certara ### 2415651###Panelist###Senior Scientific Advisor###Certara###Panelist: Stephen Duffull, PhD (he/him/his) – Certara
### he/him/hisSpeaker: Michael Gertz, PhD (he/him/his) – F. Hoffmann-La Roche
### he/him/hisSpeaker: Walter K. Kraft, MD (he/him/his) – Thomas Jefferson University
### he/him/hisSpeaker: Yanguang Cao, PhD (he/him/his) – University of North Carolina at Chapel Hill
### he/him/hisSpeaker: Yulia Vugmeyster, PhD – Mural Oncology
###Moderator: Wei Gao, PhD – Moderna
### @@@ Rajanikanth Madabushi, PhD – FDA ### 2379996###Speaker###Associate Director for Guidance and Scientific Policy * Director for CDER QMCoE###FDA###Speaker: Rajanikanth Madabushi, PhD – FDA
### @@@ Hao Zhu, PhD – ISoP ### 2360688###Speaker###ISoP Board Member###ISoP###Speaker: Hao Zhu, PhD – ISoP
### @@@ Robert Lionberger, PhD – FDA ### 2501890###Speaker###Director, Office of Research and Standards, Office of Generic Drugs###FDA###Speaker: Robert Lionberger, PhD – FDA
### @@@ Peter Stein, MD – The U.S. Food and Drug Administration ### 2407518###Speaker###Director, Office of New Drugs###The U.S. Food and Drug Administration###Speaker: Peter Stein, MD – The U.S. Food and Drug Administration
###Speaker: Jeff Kearns, PhD (he/him/his) – Novartis
### he/him/hisSpeaker: John C. Panetta, PhD (he/him/his) – St Jude Children's Research Hospital
### he/him/hisSpeaker: Jennifer Monroy, CAE – ISoP
### @@@ Vijay Ivaturi, PhD – PUMAS Inc ### 2343541###Speaker###Principal scientist PUMAS###PUMAS Inc###Speaker: Vijay Ivaturi, PhD – PUMAS Inc
### @@@ Tawanda Gumbo, MD (he/him/his) – CEO, Phase Advance AI ### 2380003###Speaker###Professor of Medicine###CEO, Phase Advance AI###Speaker: Tawanda Gumbo, MD (he/him/his) – CEO, Phase Advance AI
### he/him/hisSpeaker: Mark Lovern, PhD (he/him/his) – InSilicoTrials
### he/him/his @@@ Daniel Roeshammar ### 2343537###Speaker#########Speaker: Daniel Roeshammar
###Chair: Alice Zong, MSPH – Johnson & Johnson
### @@@ Rajat Desikan, PhD (he/him/his) – Clinical Pharmacology Modelling & Simulation – Vaccines & Infectious Diseases, Precision Medicine, GSK ### 2360727###Chair and Speaker###Director###Clinical Pharmacology Modelling & Simulation – Vaccines & Infectious Diseases, Precision Medicine, GSK###Chair and Speaker: Rajat Desikan, PhD (he/him/his) – Clinical Pharmacology Modelling & Simulation – Vaccines & Infectious Diseases, Precision Medicine, GSK
### he/him/his @@@ Jane PF Bai, PhD (she/her/hers) – Center for Drug Evaluation and Research, US Food and Drug Administration ### 2360704###Speaker###Expert Regulatory Scientist (Systems Pharmacology)###Center for Drug Evaluation and Research, US Food and Drug Administration###Speaker: Jane PF Bai, PhD (she/her/hers) – Center for Drug Evaluation and Research, US Food and Drug Administration
### she/her/hers @@@ Ryan Suderman, PhD (he/him/his) – Simulations Plus, Inc. ### 2360730###Speaker###Associate Director/Sr. Principal Scientist###Simulations Plus, Inc.###Speaker: Ryan Suderman, PhD (he/him/his) – Simulations Plus, Inc.
### he/him/his @@@ Tongli Zhang, PhD (he/him/his) – College of Medicine University of Cincinnati ### 2360732###Panelist###Associate Professor Pharmacology & Systems Physiology###College of Medicine University of Cincinnati###Panelist: Tongli Zhang, PhD (he/him/his) – College of Medicine University of Cincinnati
### he/him/his @@@ Corey J. Bishop, PhD (he/him/his) – Clinical Pharmacology and Pharmacometrics Johnson & Johnson ### 2360731###Panelist###Senior Principal Scientist###Clinical Pharmacology and Pharmacometrics Johnson & Johnson###Panelist: Corey J. Bishop, PhD (he/him/his) – Clinical Pharmacology and Pharmacometrics Johnson & Johnson
### he/him/hisSpeaker: Francesco Brizzi, PhD (he/him/his) – Predictive Modelling and Data Analytics, Roche Pharma Research & Early Development, Roche Innovation Center Basel, Switzerland
### he/him/hisSpeaker: Lisl Shoda, PhD (she/her/hers) – Simulations Plus Inc
### she/her/hersSpeaker: Jared Weddell, PhD – Astellas
###Speaker: Neelima Thanneer, MS – BMS
###Speaker: Timothy Waterhouse, PhD (he/him/his) – Metrum Research Group
### he/him/hisSpeaker: Mirwais Wardak, PhD (he/him/his) – Genentech, Inc.
### he/him/hisSpeaker: Nitin Mehrotra, Phd – Alnylam Pharmaceuticals
###Speaker: Suein Choi, MD., PhD. (she/her/hers) – Catholic university of Korea
### she/her/hersSpeaker: Omid Bazgir, PhD (he/him/his) – Genentech Inc.
### he/him/hisChair and Speaker: Dongyang Liu, PhD (he/him/his) – Drug Clinical Trial Center, Peking University Third Hospital
### he/him/his @@@ Aleksandra Galetin, PhD (she/her/hers) – University of Manchester ### 2379986###Chair and Speaker###Professor of Translational Pharmacokinetics ###University of Manchester###Chair and Speaker: Aleksandra Galetin, PhD (she/her/hers) – University of Manchester
### she/her/hers @@@ Michael Gertz, PhD (he/him/his) – F. Hoffmann-La Roche ### 2413383###Speaker###Expert Scientist###F. Hoffmann-La Roche###Speaker: Michael Gertz, PhD (he/him/his) – F. Hoffmann-La Roche
### he/him/his @@@ Lixia Zhang, PhD – FDA ### 2413382###Speaker###Staff Fellow###FDA###Speaker: Lixia Zhang, PhD – FDA
###Facilitator: Peter Bonate, PhD – Executive Director at Astellas/ Editor-in-Chief, JPKPD
###Chair and Speaker: Mirwais Wardak, PhD (he/him/his) – Genentech, Inc.
### he/him/his @@@ Owen Richfield, PhD – Yale University ### 2360744###Co-Chair###Postdoctoral Fellow###Yale University###Co-Chair: Owen Richfield, PhD – Yale University
### @@@ Marc D. Normandin, PhD (he/him/his) – Yale University ### 2360745###Speaker###Director of Yale PET Core, Associate Professor of Radiology & Biomedical Imaging###Yale University###Speaker: Marc D. Normandin, PhD (he/him/his) – Yale University
### he/him/his @@@ Guobao Wang, PhD (he/him/his) – University of California, Davis ### 2360746###Speaker###Professor of Radiology###University of California, Davis###Speaker: Guobao Wang, PhD (he/him/his) – University of California, Davis
### he/him/hisSpeaker: Yanguang Cao, PhD (he/him/his) – University of North Carolina at Chapel Hill
### he/him/hisSpeaker: Neelima Thanneer, MS – BMS
###Chair: Nieves Velez de Mendizabal, PhD (she/her/hers) – Eli Lilly and Company
### she/her/hers @@@ Stacey Tannenbaum, PhD, FISoP (she/her/hers) – Metrum Research Group ### 2360692###Chair###VP of Scientific Engagement###Metrum Research Group###Chair: Stacey Tannenbaum, PhD, FISoP (she/her/hers) – Metrum Research Group
### she/her/hers @@@ Ana Ruiz, PharmD, PhD – Gilead Sciences ### 2360693###Panelist###Executive Director, Head of the Pharmacometrics Group###Gilead Sciences###Panelist: Ana Ruiz, PharmD, PhD – Gilead Sciences
### @@@ Julia Korell, PhD (she/her/hers) – Metrum Research Group ### 2360694###Panelist###Principal Scientist II###Metrum Research Group###Panelist: Julia Korell, PhD (she/her/hers) – Metrum Research Group
### she/her/hers @@@ Gemma Dickinson, PhD (she/her/hers) – Eli Lilly and Company ### 2360695###Panelist###Vice President and Head of Global PK/PD and Pharmacometrics###Eli Lilly and Company###Panelist: Gemma Dickinson, PhD (she/her/hers) – Eli Lilly and Company
### she/her/hers @@@ Joga Gobburu, PhD MBA (he/him/his) – University of Maryland ### 2380204###Panelist###Professor###University of Maryland###Panelist: Joga Gobburu, PhD MBA (he/him/his) – University of Maryland
### he/him/hisSpeaker: Mirjam Trame, Ph.D (she/her/hers) – Certara
### she/her/hersSpeaker: Antoine Pitoy, PhD student – INSERM / Université Paris Cité
###Keynote Speaker: Peter Stein, MD – The U.S. Food and Drug Administration
###Speaker: Tamara van Steeg – LAP&P Consultants BV
### @@@ Sven Hoefman ### 2343517###Speaker#########Speaker: Sven Hoefman
### @@@ Richard Hooijmaijers ### 2343518###Speaker#########Speaker: Richard Hooijmaijers
###Speaker: Tamara van Steeg – LAP&P Consultants BV
### @@@ Sven Hoefman ### 2343517###Speaker#########Speaker: Sven Hoefman
### @@@ Richard Hooijmaijers ### 2343518###Speaker#########Speaker: Richard Hooijmaijers
###Speaker: Lang Li, PhD – Department of Biomedical Informatics, College of Medicine, The Ohio State University
###Speaker: Dongfen Yuan, PhD – Janssen Research & Development
###Speaker: Paolo Vicini, PhD, MBA (he/him/his) – Confo Therapeutics
### he/him/hisChair: Isabel M. Figueroa, PhD – Gilead
### @@@ Iraj Hosseini, Distinguished Scientist/Group Head/Pharmacology Team Leader – Genentech ### 2360734###Chair###Distinguished Scientist###Genentech###Chair: Iraj Hosseini, Distinguished Scientist/Group Head/Pharmacology Team Leader – Genentech
### @@@ Jin Niu, PhD (she/her/hers) – J&J ### 2360735###Speaker###Senior Scientist###J&J###Speaker: Jin Niu, PhD (she/her/hers) – J&J
### she/her/hers @@@ Brian Schmidt ### 2407942###Speaker#########Speaker: Brian Schmidt
### @@@ Alexander Kulesza, PhD (he/him/his) – Systems Pharmacology Lead ### 2343520###Speaker###Principal Scientist###Systems Pharmacology Lead###Speaker: Alexander Kulesza, PhD (he/him/his) – Systems Pharmacology Lead
### he/him/hisSpeaker: Donald E. Mager, PharmD, PhD (he/him/his) – University at Buffalo, SUNY
### he/him/hisSpeaker: Damilola O. Olabode, PhD (she/her/hers) – Quantitative Clinical Pharmacology, AstraZeneca
### she/her/hersSpeaker: Seth Robey, PhD (he/him/his) – Merck & Co., Inc.
### he/him/hisSpeaker: Mitch Phelps, PhD (he/him/his) – The Ohio State University
### he/him/hisSpeaker: Xinwen Zhang, PhD – Clinical Pharmacology Modeling & Simulation, Amgen
###Speaker: Katharina Wilkins, PhD (she/her/hers) – Metrum Research Group
### she/her/hersSpeaker: James Lu, PhD (he/him/his) – Clinical Pharmacology, Genentech Inc.
### he/him/hisSpeaker: Eleni Caratzas, MSc, PhD – Janssen RnD
###Chair: Georgi Kapitanov, PhD – Certara
### @@@ Amita Joshi, PhD (she/her/hers) – Genentech, South San Francisco, CA ### 2360737###Chair###Vice President, Clinical Pharmacology###Genentech, South San Francisco, CA###Chair: Amita Joshi, PhD (she/her/hers) – Genentech, South San Francisco, CA
### she/her/hers @@@ Mirjam Trame, Ph.D (she/her/hers) – Certara ### 2360657###Speaker###Vice President Pharmacometrics###Certara###Speaker: Mirjam Trame, Ph.D (she/her/hers) – Certara
### she/her/hers @@@ Kapil Gadkar, PhD – Genentech ### 2407912###Speaker###Distinguished Scientist, Senior Director###Genentech###Speaker: Kapil Gadkar, PhD – Genentech
### @@@ Blerta Shtylla, PhD (she/her/hers) – Pharmacometrics & Systems Pharmacology, Pfizer Research and Development, La Jolla, CA ### 2360738###Speaker###Research Fellow###Pharmacometrics & Systems Pharmacology, Pfizer Research and Development, La Jolla, CA###Speaker: Blerta Shtylla, PhD (she/her/hers) – Pharmacometrics & Systems Pharmacology, Pfizer Research and Development, La Jolla, CA
### she/her/hers @@@ C.J. Musante, PhD – Pfizer ### 2407910###Panelist###VP & Global Head of Pharmacometrics & Systems Pharmacology###Pfizer###Panelist: C.J. Musante, PhD – Pfizer
### @@@ Jin Jin, PhD (she/her/hers) – Genentech, Inc. ### 2407911###Panelist###Executive Director and Senior Fellow###Genentech, Inc.###Panelist: Jin Jin, PhD (she/her/hers) – Genentech, Inc.
### she/her/hers @@@ Justin C. Earp, PhD – United States FDA ### 2481300###Panelist###Pharmacometrics Team Lead###United States FDA###Panelist: Justin C. Earp, PhD – United States FDA
### @@@ Anna Kondic, anna.kondic@bms.com – Bristol Myers Squibb ### 2457387###Panelist######Bristol Myers Squibb###Panelist: Anna Kondic, anna.kondic@bms.com – Bristol Myers Squibb
###Speaker: Ivelina Gueorguieva, PhD (she/her/hers) – Eli Lilly and Company
### she/her/hersSpeaker: Tommy Li, PhD – Genmab
###Speaker: Donghua Yin, PhD – Pfizer
###Speaker: Sara Quinney, PharmD, PhD (she/her/hers) – Indiana University School of Medicine
### she/her/hersChair: Karen Rowland Yeo, PhD – Certara UK Ltd
### @@@ Priya Jayachandran, PharmD, MSE (she/her/hers) – Regeneron Pharmaceuticals, Inc. ### 2360722###Chair###Associate Director, Quantitative Pharmacologist###Regeneron Pharmaceuticals, Inc.###Chair: Priya Jayachandran, PharmD, MSE (she/her/hers) – Regeneron Pharmaceuticals, Inc.
### she/her/hers @@@ Catriona Waitt, MBChB, PhD – University of Liverpool, UK and Infectious Diseases Institute, Makerere University, Uganda ### 2360724###Speaker###Professor of Clinical Pharmacology & Global Health###University of Liverpool, UK and Infectious Diseases Institute, Makerere University, Uganda###Speaker: Catriona Waitt, MBChB, PhD – University of Liverpool, UK and Infectious Diseases Institute, Makerere University, Uganda
### @@@ Sara Quinney, PharmD, PhD (she/her/hers) – Indiana University School of Medicine ### 2407908###Speaker###Professor of OB/GYN###Indiana University School of Medicine###Speaker: Sara Quinney, PharmD, PhD (she/her/hers) – Indiana University School of Medicine
### she/her/hers @@@ Walter K. Kraft, MD (he/him/his) – Thomas Jefferson University ### 2360723###Speaker###Professor of Pharmacology, Surgery and Medicine###Thomas Jefferson University###Speaker: Walter K. Kraft, MD (he/him/his) – Thomas Jefferson University
### he/him/his @@@ Elimika Pfuma Fletcher, PharmD, PhD (she/her/hers) – U.S. Food and Drug Administration ### 2360725###Speaker###Clinical Pharmacology Policy Lead ###U.S. Food and Drug Administration###Speaker: Elimika Pfuma Fletcher, PharmD, PhD (she/her/hers) – U.S. Food and Drug Administration
### she/her/hers @@@ Lang Li, PhD – Department of Biomedical Informatics, College of Medicine, The Ohio State University ### 2407905###Speaker###Professor and Chair###Department of Biomedical Informatics, College of Medicine, The Ohio State University###Speaker: Lang Li, PhD – Department of Biomedical Informatics, College of Medicine, The Ohio State University
###Speaker: Wojciech Krzyzanski, n/a – University at Buffalo
### @@@ Shuhua Hu, PhD – Certara ### 2343535###Speaker###Principal Research Scientist###Certara###Speaker: Shuhua Hu, PhD – Certara
###Speaker: Robert Bauer
### @@@ Brian Sadler ### 2343526###Speaker#########Speaker: Brian Sadler
###Chair: Yuqing Gong, PhD (she/her/hers) – Division of Quantitative Methods and Modeling, Office of Research and Standards, Office of Generic Drugs, Center for Drug Evaluation and Research, U.S. Food and Drug Administration
### she/her/hers @@@ Robert R. Bies, Pharm.D. PhD FISoP – Department of Pharmaceutical Sciences, School of Pharmacy and Pharmaceutical Sciences, University at Buffalo ### 2360705###Chair and Speaker###Professor of Pharmaceutical Sciences, Associate Dean of Graduate Studies, School of Pharmacy###Department of Pharmaceutical Sciences, School of Pharmacy and Pharmaceutical Sciences, University at Buffalo###Chair and Speaker: Robert R. Bies, Pharm.D. PhD FISoP – Department of Pharmaceutical Sciences, School of Pharmacy and Pharmaceutical Sciences, University at Buffalo
### @@@ Andrew C. Hooker, PhD, ISOP member – Uppsala University ### 2360680###Speaker###Professor of Pharmacometrics###Uppsala University###Speaker: Andrew C. Hooker, PhD, ISOP member – Uppsala University
### @@@ Liang Zhao, PhD (he/him/his) – Department of Bioengineering and Therapeutic Sciences, School of Pharmacy, UCSF ### 2360729###Speaker###Professor###Department of Bioengineering and Therapeutic Sciences, School of Pharmacy, UCSF###Speaker: Liang Zhao, PhD (he/him/his) – Department of Bioengineering and Therapeutic Sciences, School of Pharmacy, UCSF
### he/him/hisChair and Speaker: James Lu, PhD (he/him/his) – Clinical Pharmacology, Genentech Inc.
### he/him/his @@@ Diansong Zhou, PhD – Quantitative Clinical Pharmacology, AstraZeneca ### 2360672###Chair###Senior Director###Quantitative Clinical Pharmacology, AstraZeneca###Chair: Diansong Zhou, PhD – Quantitative Clinical Pharmacology, AstraZeneca
### @@@ Nazanin Ahmadi Daryakenari, PhD Candidate (she/her/hers) – Biomedical Engineering, Brown University ### 2360673###Speaker###Research Assistant###Biomedical Engineering, Brown University###Speaker: Nazanin Ahmadi Daryakenari, PhD Candidate (she/her/hers) – Biomedical Engineering, Brown University
### she/her/hers @@@ Damilola O. Olabode, PhD (she/her/hers) – Quantitative Clinical Pharmacology, AstraZeneca ### 2360674###Speaker###Associate Director###Quantitative Clinical Pharmacology, AstraZeneca###Speaker: Damilola O. Olabode, PhD (she/her/hers) – Quantitative Clinical Pharmacology, AstraZeneca
### she/her/hersSpeaker: Theodore Lystig, MS, PhD – BridgeBio
###Speaker: Liping Zhang, PhD (she/her/hers) – Johnson and Johnson
### she/her/hersSpeaker: Sebastiaan C. Goulooze, PhD (he/him/his) – LAP&P Consultants BV
### he/him/hisChair: Yan Ji, PhD – Novartis
### @@@ Molly Zhao, PhD – Gilead Sciences ### 2360710###Co-Chair###Director###Gilead Sciences###Co-Chair: Molly Zhao, PhD – Gilead Sciences
### @@@ Jeffrey West, PhD – H. Lee Moffitt Cancer Center & Research Institute ### 2408931###Speaker###Assistant Member###H. Lee Moffitt Cancer Center & Research Institute###Speaker: Jeffrey West, PhD – H. Lee Moffitt Cancer Center & Research Institute
### @@@ Yanguang Cao, PhD (he/him/his) – University of North Carolina at Chapel Hill ### 2360726###Speaker###Associate Professor###University of North Carolina at Chapel Hill###Speaker: Yanguang Cao, PhD (he/him/his) – University of North Carolina at Chapel Hill
### he/him/his @@@ Birgit Schoeberl, PhD – Novartis ### 2360742###Speaker###Global Head of Translational Modeling & Simulation and Data Science###Novartis###Speaker: Birgit Schoeberl, PhD – Novartis
###Panelist: Ana Ruiz, PharmD, PhD – Gilead Sciences
### @@@ Julia Korell, PhD (she/her/hers) – Metrum Research Group ### 2360694###Panelist###Principal Scientist II###Metrum Research Group###Panelist: Julia Korell, PhD (she/her/hers) – Metrum Research Group
### she/her/hers @@@ Gemma Dickinson, PhD (she/her/hers) – Eli Lilly and Company ### 2360695###Panelist###Vice President and Head of Global PK/PD and Pharmacometrics###Eli Lilly and Company###Panelist: Gemma Dickinson, PhD (she/her/hers) – Eli Lilly and Company
### she/her/hers @@@ Joga Gobburu, PhD MBA (he/him/his) – University of Maryland ### 2380204###Panelist###Professor###University of Maryland###Panelist: Joga Gobburu, PhD MBA (he/him/his) – University of Maryland
### he/him/his @@@ Peter Bonate, PhD – Executive Director at Astellas/ Editor-in-Chief, JPKPD ### 2360753###Panelist###Executive Director###Executive Director at Astellas/ Editor-in-Chief, JPKPD###Panelist: Peter Bonate, PhD – Executive Director at Astellas/ Editor-in-Chief, JPKPD
###Panelist: Neelima Thanneer, MS – BMS
### @@@ Xiaobin Li, M.S – GSK ### 2407936###Panelist###Programming Director, CPMS Programming and Business Excellence###GSK###Panelist: Xiaobin Li, M.S – GSK
### @@@ Alice Zong, MSPH – Johnson & Johnson ### 2360709###Panelist###Associate Director, Clinical Pharmacology and Pharmacometrics###Johnson & Johnson###Panelist: Alice Zong, MSPH – Johnson & Johnson
###Panelist: Walter K. Kraft, MD (he/him/his) – Thomas Jefferson University
### he/him/his @@@ Catriona Waitt, MBChB, PhD – University of Liverpool, UK and Infectious Diseases Institute, Makerere University, Uganda ### 2360724###Panelist###Professor of Clinical Pharmacology & Global Health###University of Liverpool, UK and Infectious Diseases Institute, Makerere University, Uganda###Panelist: Catriona Waitt, MBChB, PhD – University of Liverpool, UK and Infectious Diseases Institute, Makerere University, Uganda
### @@@ Elimika Pfuma Fletcher, PharmD, PhD (she/her/hers) – U.S. Food and Drug Administration ### 2360725###Panelist###Clinical Pharmacology Policy Lead ###U.S. Food and Drug Administration###Panelist: Elimika Pfuma Fletcher, PharmD, PhD (she/her/hers) – U.S. Food and Drug Administration
### she/her/hers @@@ Lang Li, PhD – Department of Biomedical Informatics, College of Medicine, The Ohio State University ### 2407905###Panelist###Professor and Chair###Department of Biomedical Informatics, College of Medicine, The Ohio State University###Panelist: Lang Li, PhD – Department of Biomedical Informatics, College of Medicine, The Ohio State University
### @@@ Sara Quinney, PharmD, PhD (she/her/hers) – Indiana University School of Medicine ### 2407908###Panelist###Professor of OB/GYN###Indiana University School of Medicine###Panelist: Sara Quinney, PharmD, PhD (she/her/hers) – Indiana University School of Medicine
### she/her/hersPanelist: Julie A. Stone, PhD – Merck & Co., Inc.
### @@@ Youfang Cao, PhD – Eisai, Inc ### 2360717###Panelist###Director of Pharmacometrics###Eisai, Inc###Panelist: Youfang Cao, PhD – Eisai, Inc
### @@@ Brian A. Willis, PhD (he/him/his) – Biogen ### 2360718###Panelist###Head of Pharmacometrics###Biogen###Panelist: Brian A. Willis, PhD (he/him/his) – Biogen
### he/him/his @@@ Ivelina Gueorguieva, PhD (she/her/hers) – Eli Lilly and Company ### 2360719###Panelist###Sr Director, Global PK/PD and Pharmacometrics###Eli Lilly and Company###Panelist: Ivelina Gueorguieva, PhD (she/her/hers) – Eli Lilly and Company
### she/her/hers @@@ Stephen Duffull, PhD (he/him/his) – Certara ### 2415651###Panelist###Senior Scientific Advisor###Certara###Panelist: Stephen Duffull, PhD (he/him/his) – Certara
### he/him/hisPanelist: Amita Joshi, PhD (she/her/hers) – Genentech, South San Francisco, CA
### she/her/hers @@@ Mirjam Trame, Ph.D (she/her/hers) – Certara ### 2360657###Panelist###Vice President Pharmacometrics###Certara###Panelist: Mirjam Trame, Ph.D (she/her/hers) – Certara
### she/her/hers @@@ Blerta Shtylla, PhD (she/her/hers) – Pharmacometrics & Systems Pharmacology, Pfizer Research and Development, La Jolla, CA ### 2360738###Panelist###Research Fellow###Pharmacometrics & Systems Pharmacology, Pfizer Research and Development, La Jolla, CA###Panelist: Blerta Shtylla, PhD (she/her/hers) – Pharmacometrics & Systems Pharmacology, Pfizer Research and Development, La Jolla, CA
### she/her/hers @@@ Kapil Gadkar, PhD – Genentech ### 2407912###Panelist###Distinguished Scientist, Senior Director###Genentech###Panelist: Kapil Gadkar, PhD – Genentech
### @@@ C.J. Musante, PhD – Pfizer ### 2407910###Panelist###VP & Global Head of Pharmacometrics & Systems Pharmacology###Pfizer###Panelist: C.J. Musante, PhD – Pfizer
### @@@ Jin Jin, PhD (she/her/hers) – Genentech, Inc. ### 2407911###Panelist###Executive Director and Senior Fellow###Genentech, Inc.###Panelist: Jin Jin, PhD (she/her/hers) – Genentech, Inc.
### she/her/hers @@@ Anna Kondic, anna.kondic@bms.com – Bristol Myers Squibb ### 2457387###Panelist######Bristol Myers Squibb###Panelist: Anna Kondic, anna.kondic@bms.com – Bristol Myers Squibb
###Panelist: Rajat Desikan, PhD (he/him/his) – Clinical Pharmacology Modelling & Simulation – Vaccines & Infectious Diseases, Precision Medicine, GSK
### he/him/his @@@ Jane PF Bai, PhD (she/her/hers) – Center for Drug Evaluation and Research, US Food and Drug Administration ### 2360704###Panelist###Expert Regulatory Scientist (Systems Pharmacology)###Center for Drug Evaluation and Research, US Food and Drug Administration###Panelist: Jane PF Bai, PhD (she/her/hers) – Center for Drug Evaluation and Research, US Food and Drug Administration
### she/her/hers @@@ Ryan Suderman, PhD (he/him/his) – Simulations Plus, Inc. ### 2360730###Panelist###Associate Director/Sr. Principal Scientist###Simulations Plus, Inc.###Panelist: Ryan Suderman, PhD (he/him/his) – Simulations Plus, Inc.
### he/him/his @@@ Tongli Zhang, PhD (he/him/his) – College of Medicine University of Cincinnati ### 2360732###Panelist###Associate Professor Pharmacology & Systems Physiology###College of Medicine University of Cincinnati###Panelist: Tongli Zhang, PhD (he/him/his) – College of Medicine University of Cincinnati
### he/him/his @@@ Corey J. Bishop, PhD (he/him/his) – Clinical Pharmacology and Pharmacometrics Johnson & Johnson ### 2360731###Panelist###Senior Principal Scientist###Clinical Pharmacology and Pharmacometrics Johnson & Johnson###Panelist: Corey J. Bishop, PhD (he/him/his) – Clinical Pharmacology and Pharmacometrics Johnson & Johnson
### he/him/hisPanelist: Joy C. Hsu, PhD – Genentech
### @@@ Hao Zhu, PhD – ISoP ### 2360688###Panelist###ISoP Board Member###ISoP###Panelist: Hao Zhu, PhD – ISoP
### @@@ Francesco Brizzi, PhD (he/him/his) – Predictive Modelling and Data Analytics, Roche Pharma Research & Early Development, Roche Innovation Center Basel, Switzerland ### 2360747###Panelist###Senior Scientist###Predictive Modelling and Data Analytics, Roche Pharma Research & Early Development, Roche Innovation Center Basel, Switzerland###Panelist: Francesco Brizzi, PhD (he/him/his) – Predictive Modelling and Data Analytics, Roche Pharma Research & Early Development, Roche Innovation Center Basel, Switzerland
### he/him/his @@@ Niklas Korsbo, Ph.D. (he/him/his) – DeepPumas, Pumas-AI Inc. ### 2343539###Panelist###Senior Product Engineer###DeepPumas, Pumas-AI Inc.###Panelist: Niklas Korsbo, Ph.D. (he/him/his) – DeepPumas, Pumas-AI Inc.
### he/him/hisPanelist: Hao Zhu, PhD – ISoP
### @@@ Hao-Jie Zhu, PhD – University of Michigan College of Pharmacy ### 2408503###Panelist###Professor###University of Michigan College of Pharmacy###Panelist: Hao-Jie Zhu, PhD – University of Michigan College of Pharmacy
### @@@ Lourdes Cucurull-Sanchez, PhD MPhil (she/her/hers) – Pharmetheus ### 2380006###Panelist###Platform Scientific Lead###Pharmetheus###Panelist: Lourdes Cucurull-Sanchez, PhD MPhil (she/her/hers) – Pharmetheus
### she/her/hers @@@ Yuan Xiong, PhD – Johnson & Johnson ### 2380009###Panelist###Director###Johnson & Johnson###Panelist: Yuan Xiong, PhD – Johnson & Johnson
### @@@ Neelima Thanneer, MS – BMS ### 2360663###Panelist###Executive Director, Head of Data Science and Clin Pharm Analysis & Reporting###BMS###Panelist: Neelima Thanneer, MS – BMS
### @@@ Jiawei Zhou, PhD (she/her/hers) – Pfizer, Inc. ### 2360697###Panelist###Manager, Pharmacometrics & Systems Pharmacology###Pfizer, Inc.###Panelist: Jiawei Zhou, PhD (she/her/hers) – Pfizer, Inc.
### she/her/hersPanelist: Jingqi Gong, PhD (she/her/hers) – GlaxoSmithKline
### she/her/hers @@@ Oleg Demin Jr (he/him/his) – InSysBio CY ### 2360667###Panelist###Scientific Director, Oncology & Immuno-Oncology Quantitative Systems Pharmacology###InSysBio CY###Panelist: Oleg Demin Jr (he/him/his) – InSysBio CY
### he/him/his @@@ Richard Allen, PhD – Pfizer ### 2360668###Panelist###Research Fellow and Quantitative Systems Pharmacology Lead###Pfizer###Panelist: Richard Allen, PhD – Pfizer
### @@@ Susana Zaph, PhD (she/her/hers) – Sanofi ### 2360669###Panelist###Senior Director & Head of Translational Disease Modeling - US###Sanofi###Panelist: Susana Zaph, PhD (she/her/hers) – Sanofi
### she/her/hersPanelist: Richard Allen, PhD – Pfizer
### @@@ Brian Schmidt ### 2407942###Panelist#########Panelist: Brian Schmidt
### @@@ Jin Jin, PhD (she/her/hers) – Genentech, Inc. ### 2407911###Panelist###Executive Director and Senior Fellow###Genentech, Inc.###Panelist: Jin Jin, PhD (she/her/hers) – Genentech, Inc.
### she/her/hers @@@ Lourdes Cucurull-Sanchez, PhD MPhil (she/her/hers) – Pharmetheus ### 2380006###Panelist###Platform Scientific Lead###Pharmetheus###Panelist: Lourdes Cucurull-Sanchez, PhD MPhil (she/her/hers) – Pharmetheus
### she/her/hers @@@ Susana Zaph, PhD (she/her/hers) – Sanofi ### 2360669###Panelist###Senior Director & Head of Translational Disease Modeling - US###Sanofi###Panelist: Susana Zaph, PhD (she/her/hers) – Sanofi
### she/her/hersSpeaker: Dongyang Liu, PhD (he/him/his) – Drug Clinical Trial Center, Peking University Third Hospital
### he/him/his @@@ Michael Gertz, PhD (he/him/his) – F. Hoffmann-La Roche ### 2413383###Speaker###Expert Scientist###F. Hoffmann-La Roche###Speaker: Michael Gertz, PhD (he/him/his) – F. Hoffmann-La Roche
### he/him/his @@@ Aleksandra Galetin, PhD (she/her/hers) – University of Manchester ### 2379986###Speaker###Professor of Translational Pharmacokinetics ###University of Manchester###Speaker: Aleksandra Galetin, PhD (she/her/hers) – University of Manchester
### she/her/hers @@@ Lixia Zhang, PhD – FDA ### 2413382###Speaker###Staff Fellow###FDA###Speaker: Lixia Zhang, PhD – FDA
###Speaker: Ralph Smith, PhD – North Carolina State University
###Speaker: Brian A. Willis, PhD (he/him/his) – Biogen
### he/him/hisSpeaker: Nazanin Ahmadi Daryakenari, PhD Candidate (she/her/hers) – Biomedical Engineering, Brown University
### she/her/hersSpeaker: Jace Nielsen, Pharm.D. – Astellas
###Speaker: Marc D. Normandin, PhD (he/him/his) – Yale University
### he/him/hisSpeaker: Ahmed H. Salem, PhD, FCP – Abbvie
###Speaker: Fulden Buyukozturk, PhD – MathWorks
###Speaker: Joy C. Hsu, PhD – Genentech
### @@@ Mark Lovern, PhD (he/him/his) – InSilicoTrials ### 2343536###Speaker###Chief Platform Officer###InSilicoTrials###Speaker: Mark Lovern, PhD (he/him/his) – InSilicoTrials
### he/him/hisSpeaker: Nahor Haddish-Berhane
###Speaker: Jennifer Monroy, CAE – ISoP
### @@@ Vijay Ivaturi, PhD – PUMAS Inc ### 2343541###Speaker###Principal scientist PUMAS###PUMAS Inc###Speaker: Vijay Ivaturi, PhD – PUMAS Inc
###Speaker: Louis Joslyn, PhD – Preclinical and Translational Pharmacokinetics/Pharmacodynamics, Genentech
###Speaker: Ioannis (Yannis) Androulakis, PhD – Rutgers University
###Speaker: Atiqur Rahman, PhD – FDA
###Speaker: Oleg Demin Jr (he/him/his) – InSysBio CY
### he/him/hisSpeaker: Mengdi Tao, n/a – Sanofi US
### @@@ Alexander Ratushny – Bristol Myers Squibb ### 2453806###Speaker###Senior Director###Bristol Myers Squibb###Speaker: Alexander Ratushny – Bristol Myers Squibb
### @@@ Rohit Rao, PhD – Pfizer ### 2453967###Speaker###Quantitative Systems Pharmacologist###Pfizer###Speaker: Rohit Rao, PhD – Pfizer
### @@@ Iraj Hosseini, Distinguished Scientist/Group Head/Pharmacology Team Leader – Genentech ### 2360734###Speaker###Distinguished Scientist###Genentech###Speaker: Iraj Hosseini, Distinguished Scientist/Group Head/Pharmacology Team Leader – Genentech
###Chair: Steven Chang, n/a – Simulations Plus, Inc.
### @@@ Weirong Wang, PhD – J&J Innovative Medicine ### 2457505###Chair######J&J Innovative Medicine###Chair: Weirong Wang, PhD – J&J Innovative Medicine
### @@@ Brian Schmidt ### 2407942###Chair#########Chair: Brian Schmidt
### @@@ Mengdi Tao, n/a – Sanofi US ### 2454043###Speaker###Senior Scientist###Sanofi US###Speaker: Mengdi Tao, n/a – Sanofi US
### @@@ Alexander Ratushny – Bristol Myers Squibb ### 2453806###Speaker###Senior Director###Bristol Myers Squibb###Speaker: Alexander Ratushny – Bristol Myers Squibb
### @@@ Rohit Rao, PhD – Pfizer ### 2453967###Speaker###Quantitative Systems Pharmacologist###Pfizer###Speaker: Rohit Rao, PhD – Pfizer
### @@@ Iraj Hosseini, Distinguished Scientist/Group Head/Pharmacology Team Leader – Genentech ### 2360734###Speaker###Distinguished Scientist###Genentech###Speaker: Iraj Hosseini, Distinguished Scientist/Group Head/Pharmacology Team Leader – Genentech
### @@@ Richard Allen, PhD – Pfizer ### 2360668###Speaker###Research Fellow and Quantitative Systems Pharmacology Lead###Pfizer###Speaker: Richard Allen, PhD – Pfizer
### @@@ Jin Jin, PhD (she/her/hers) – Genentech, Inc. ### 2407911###Panelist###Executive Director and Senior Fellow###Genentech, Inc.###Panelist: Jin Jin, PhD (she/her/hers) – Genentech, Inc.
### she/her/hers @@@ Lourdes Cucurull-Sanchez, PhD MPhil (she/her/hers) – Pharmetheus ### 2380006###Panelist###Platform Scientific Lead###Pharmetheus###Panelist: Lourdes Cucurull-Sanchez, PhD MPhil (she/her/hers) – Pharmetheus
### she/her/hers @@@ Susana Zaph, PhD (she/her/hers) – Sanofi ### 2360669###Panelist###Senior Director & Head of Translational Disease Modeling - US###Sanofi###Panelist: Susana Zaph, PhD (she/her/hers) – Sanofi
### she/her/hersChair: Yan Feng, PhD (she/her/hers) – Genmab
### she/her/hers @@@ Shelly Wang, PhD (she/her/hers) – Gilead Sciences ### 2360661###Chair###Principal Scientist II###Gilead Sciences###Chair: Shelly Wang, PhD (she/her/hers) – Gilead Sciences
### she/her/hers @@@ Katharina Wilkins, PhD (she/her/hers) – Metrum Research Group ### 2360701###Speaker###Group leader, Principal scientist I, Translational and Systems Pharmacology###Metrum Research Group###Speaker: Katharina Wilkins, PhD (she/her/hers) – Metrum Research Group
### she/her/hers @@@ Rudy Gunawan, PhD – Pfizer ### 2360702###Speaker###Director, Pharmacometrics & System Pharmacology###Pfizer###Speaker: Rudy Gunawan, PhD – Pfizer
### @@@ Yangbing Li, PhD – U.S. Food and Drug Administration ### 2408373###Speaker###Senior Reviewer###U.S. Food and Drug Administration###Speaker: Yangbing Li, PhD – U.S. Food and Drug Administration
###Speaker: Ahmed Abdelhady Abozeid, PhD (he/him/his) – Intellia
### he/him/hisSpeaker: Hardik Mody, PhD (he/him/his) – Genentech
### he/him/hisSpeaker: Vivaswath S. Ayyar, PhD – J&J Innovative Medicine
###Chair: Piet van der Graaf, PharmD, PhD – Certara
### @@@ Amitava Mitra, PhD – Clinical Pharmacology ### 2360683###Chair and Speaker###Executive DIrector###Clinical Pharmacology###Chair and Speaker: Amitava Mitra, PhD – Clinical Pharmacology
### @@@ Tommy Li, PhD – Genmab ### 2360686###Speaker###Director###Genmab###Speaker: Tommy Li, PhD – Genmab
### @@@ Atiqur Rahman, PhD – FDA ### 2360685###Speaker###Division Director###FDA###Speaker: Atiqur Rahman, PhD – FDA
###Speaker: Colin W. Castleberry, PhD (he/him/his) – Amgen
### he/him/hisSpeaker: Jurgen Langenhorst
### @@@ Felicien Le Louedec, PharmD, PhD – Pharmetheus ### 2343531###Speaker###Associate Consultant###Pharmetheus###Speaker: Felicien Le Louedec, PharmD, PhD – Pharmetheus
### @@@ Joakim Nyberg, PhD (he/him/his) – Pharmetheus ### 2343532###Speaker###Chief Technology Officer###Pharmetheus###Speaker: Joakim Nyberg, PhD (he/him/his) – Pharmetheus
### he/him/his @@@ Qing Xi Ooi, PhD (she/her/hers) – Pharmetheus ### 2343533###Speaker###Senior Consultant###Pharmetheus###Speaker: Qing Xi Ooi, PhD (she/her/hers) – Pharmetheus
### she/her/hers PHARM002Speaker: Lena E. Friberg, PhD (she/her/hers) – Uppsala University
### she/her/hers @@@ Nastya Kassir, PharmD, PhD, FCP (she/her/hers) – Genentech ### 2343528###Speaker###Senior Director & Distinguished Scientist###Genentech###Speaker: Nastya Kassir, PharmD, PhD, FCP (she/her/hers) – Genentech
### she/her/hers @@@ France Mentre, PhD, MD (she/her/hers) – INSERM / Université Paris Cité ### 2343529###Speaker###Professor of Biostatistics###INSERM / Université Paris Cité###Speaker: France Mentre, PhD, MD (she/her/hers) – INSERM / Université Paris Cité
### she/her/hers PHARM001Speaker: Yangbing Li, PhD – U.S. Food and Drug Administration
###Speaker: Elimika Pfuma Fletcher, PharmD, PhD (she/her/hers) – U.S. Food and Drug Administration
### she/her/hersModerator: Emmanuel Chigutsa, PhD – Eli Lilly and Company
### @@@ Xiling Jiang, PhD – US FDA ### 2380201###Speaker###Master Clinical Pharmacologist###US FDA###Speaker: Xiling Jiang, PhD – US FDA
### @@@ Joga Gobburu, PhD MBA (he/him/his) – University of Maryland ### 2380204###Speaker###Professor###University of Maryland###Speaker: Joga Gobburu, PhD MBA (he/him/his) – University of Maryland
### he/him/his @@@ Theodore Lystig, MS, PhD – BridgeBio ### 2384719###Speaker###SVP, Chief Analytics Officer###BridgeBio###Speaker: Theodore Lystig, MS, PhD – BridgeBio
### @@@ Liping Zhang, PhD (she/her/hers) – Johnson and Johnson ### 2384721###Speaker###Senior Director###Johnson and Johnson###Speaker: Liping Zhang, PhD (she/her/hers) – Johnson and Johnson
### she/her/hers @@@ Grace V. Lee, PhD (she/her/hers) – Critical Path Institute ### 2384736###Speaker###Quantitative Medicine Scientist###Critical Path Institute###Speaker: Grace V. Lee, PhD (she/her/hers) – Critical Path Institute
### she/her/hersModerator: Fiona Glassman, PhD (she/her/hers) – Biogen
### she/her/hers @@@ Jin Dong, PhD – AstraZeneca ### 2360675###Speaker###Associate Director###AstraZeneca###Speaker: Jin Dong, PhD – AstraZeneca
### @@@ Lisl Shoda, PhD (she/her/hers) – Simulations Plus Inc ### 2384737###Speaker###Associate Vice President and Director of Immunology###Simulations Plus Inc###Speaker: Lisl Shoda, PhD (she/her/hers) – Simulations Plus Inc
### she/her/hers @@@ Fulya Akpinar Singh, PhD (she/her/hers) – Genmab ### 2384739###Speaker###Director###Genmab###Speaker: Fulya Akpinar Singh, PhD (she/her/hers) – Genmab
### she/her/hers @@@ Colin W. Castleberry, PhD (he/him/his) – Amgen ### 2446207###Speaker###Senior Scientist###Amgen###Speaker: Colin W. Castleberry, PhD (he/him/his) – Amgen
### he/him/his @@@ Suein Choi, MD., PhD. (she/her/hers) – Catholic university of Korea ### 2453965###Speaker###Research fellow###Catholic university of Korea###Speaker: Suein Choi, MD., PhD. (she/her/hers) – Catholic university of Korea
### she/her/hersModerator: Navin Goyal, PhD – Johnson and Johnson
### @@@ Jenny Chien, PhD – Eli Lilly and Company ### 2360687###Speaker###Associate Vice President###Eli Lilly and Company###Speaker: Jenny Chien, PhD – Eli Lilly and Company
### @@@ Sebastiaan C. Goulooze, PhD (he/him/his) – LAP&P Consultants BV ### 2360665###Speaker###Senior Expert Pharmacometrician###LAP&P Consultants BV###Speaker: Sebastiaan C. Goulooze, PhD (he/him/his) – LAP&P Consultants BV
### he/him/his @@@ Eleni Caratzas, MSc, PhD – Janssen RnD ### 2384740###Speaker###Senior Scientist ###Janssen RnD ###Speaker: Eleni Caratzas, MSc, PhD – Janssen RnD
### @@@ Stephan Schmidt, PhD (he/him/his) – University of Florida, Department of Pharmaceutics, Center for Pharmacometrics and Systems Pharmacology ### 2384741###Speaker###Professor and Director CPSP###University of Florida, Department of Pharmaceutics, Center for Pharmacometrics and Systems Pharmacology###Speaker: Stephan Schmidt, PhD (he/him/his) – University of Florida, Department of Pharmaceutics, Center for Pharmacometrics and Systems Pharmacology
### he/him/his @@@ Ahmed H. Salem, PhD, FCP – Abbvie ### 2384742###Speaker###Senior Research Fellow###Abbvie###Speaker: Ahmed H. Salem, PhD, FCP – Abbvie
###Moderator: Annie Lumen, PhD – Clinical Pharmacology Modeling & Simulation, Amgen
### @@@ Xinwen Zhang, PhD – Clinical Pharmacology Modeling & Simulation, Amgen ### 2384744###Speaker###Principal Scientist###Clinical Pharmacology Modeling & Simulation, Amgen###Speaker: Xinwen Zhang, PhD – Clinical Pharmacology Modeling & Simulation, Amgen
### @@@ Vincent Hurez, DVM, PhD (he/him/his) – Regeneron Pharmaceuticals Inc. ### 2487145###Speaker###Director Group Quantitative Pharmacology###Regeneron Pharmaceuticals Inc.###Speaker: Vincent Hurez, DVM, PhD (he/him/his) – Regeneron Pharmaceuticals Inc.
### he/him/his @@@ John C. Panetta, PhD (he/him/his) – St Jude Children's Research Hospital ### 2384747###Speaker###Biomedical Modeler###St Jude Children's Research Hospital###Speaker: John C. Panetta, PhD (he/him/his) – St Jude Children's Research Hospital
### he/him/his @@@ Wilhelmus E.A. De Witte, PhD – ESQlabs ### 2343519###Speaker###Lead Large Molecule Platform - Principal Scientist###ESQlabs###Speaker: Wilhelmus E.A. De Witte, PhD – ESQlabs
### @@@ Zackary R. Kenz, PhD – Simulations Plus ### 2453910###Speaker###Principal Scientist###Simulations Plus###Speaker: Zackary R. Kenz, PhD – Simulations Plus
###Speaker: Niklas Korsbo, Ph.D. (he/him/his) – DeepPumas, Pumas-AI Inc.
### he/him/his @@@ Mohamed Tarek, PhD – Pumas-AI Inc., USA ### 2343540###Speaker###Senior Product Engineer###Pumas-AI Inc., USA###Speaker: Mohamed Tarek, PhD – Pumas-AI Inc., USA
### @@@ Vijay Ivaturi, PhD – PUMAS Inc ### 2343541###Speaker###Principal scientist PUMAS###PUMAS Inc###Speaker: Vijay Ivaturi, PhD – PUMAS Inc
### @@@ Andreas Noack, PhD – PumasAI ### 2343542###Speaker###Head of Product Development###PumasAI###Speaker: Andreas Noack, PhD – PumasAI
### PUMAS002Speaker: Niklas Korsbo, Ph.D. (he/him/his) – DeepPumas, Pumas-AI Inc.
### he/him/his @@@ Mohamed Tarek, PhD – Pumas-AI Inc., USA ### 2343540###Speaker###Senior Product Engineer###Pumas-AI Inc., USA###Speaker: Mohamed Tarek, PhD – Pumas-AI Inc., USA
### @@@ Vijay Ivaturi, PhD – PUMAS Inc ### 2343541###Speaker###Principal scientist PUMAS###PUMAS Inc###Speaker: Vijay Ivaturi, PhD – PUMAS Inc
### @@@ Andreas Noack, PhD – PumasAI ### 2343542###Speaker###Head of Product Development###PumasAI###Speaker: Andreas Noack, PhD – PumasAI
### PUMAS001Chair: Jing Su, MS – Merck & Co., Inc.
### @@@ Neelima Thanneer, MS – BMS ### 2360663###Chair and Speaker###Executive Director, Head of Data Science and Clin Pharm Analysis & Reporting###BMS###Chair and Speaker: Neelima Thanneer, MS – BMS
### @@@ Xiaobin Li, M.S – GSK ### 2407936###Speaker###Programming Director, CPMS Programming and Business Excellence###GSK###Speaker: Xiaobin Li, M.S – GSK
### @@@ Alice Zong, MSPH – Johnson & Johnson ### 2360709###Panelist###Associate Director, Clinical Pharmacology and Pharmacometrics###Johnson & Johnson###Panelist: Alice Zong, MSPH – Johnson & Johnson
###Speaker: Abdallah Derbalah
### @@@ Felix Stader, PhD (he/him/his) – Certara ### 2343512###Speaker###Associate Principal Scientist###Certara###Speaker: Felix Stader, PhD (he/him/his) – Certara
### he/him/hisModerator: Nitin Mehrotra, Phd – Alnylam Pharmaceuticals
### @@@ Jeff Kearns, PhD (he/him/his) – Novartis ### 2363738###Speaker###Director, Translational Modeling & Simulation###Novartis###Speaker: Jeff Kearns, PhD (he/him/his) – Novartis
### he/him/his @@@ Vivaswath S. Ayyar, PhD – J&J Innovative Medicine ### 2363739###Speaker###Associate Scientific Director###J&J Innovative Medicine###Speaker: Vivaswath S. Ayyar, PhD – J&J Innovative Medicine
### @@@ Nitin Mehrotra, Phd – Alnylam Pharmaceuticals ### 2363737###Speaker###Head of Pharmacometrics###Alnylam Pharmaceuticals###Speaker: Nitin Mehrotra, Phd – Alnylam Pharmaceuticals
###Speaker: Xiaonan Li, PhD (she/her/hers) – Takeda Pharmaceuticals
### she/her/hersChair: Wonkyung Byon, PhD – Vertex
### @@@ Shelly Wang, PhD (she/her/hers) – Gilead Sciences ### 2360661###Chair###Principal Scientist II###Gilead Sciences###Chair: Shelly Wang, PhD (she/her/hers) – Gilead Sciences
### she/her/hers @@@ Jace Nielsen, Pharm.D. – Astellas ### 2360662###Speaker###Exploratory Development Fellow###Astellas###Speaker: Jace Nielsen, Pharm.D. – Astellas
### @@@ Neelima Thanneer, MS – BMS ### 2360663###Speaker###Executive Director, Head of Data Science and Clin Pharm Analysis & Reporting###BMS###Speaker: Neelima Thanneer, MS – BMS
### @@@ Yali Liang, MD – Jazz Pharmaceuticals ### 2391340###Speaker###Director###Jazz Pharmaceuticals###Speaker: Yali Liang, MD – Jazz Pharmaceuticals
###Speaker: Ryan Suderman, PhD (he/him/his) – Simulations Plus, Inc.
### he/him/hisSpeaker: Blerta Shtylla, PhD (she/her/hers) – Pharmacometrics & Systems Pharmacology, Pfizer Research and Development, La Jolla, CA
### she/her/hersSpeaker: Dongyang Liu, PhD (he/him/his) – Drug Clinical Trial Center, Peking University Third Hospital
### he/him/hisSpeaker: Andrew C. Hooker, PhD, ISOP member – Uppsala University
###Speaker: Wilhelmus E.A. De Witte, PhD – ESQlabs
###Chair: Jiawei Zhou, PhD (she/her/hers) – Pfizer, Inc.
### she/her/hers @@@ Luke Fostvedt, PhD – Pfizer, Inc. ### 2360696###Chair###Director, Pharmacometrics & Systems Pharmacology###Pfizer, Inc.###Chair: Luke Fostvedt, PhD – Pfizer, Inc.
### @@@ Timothy Waterhouse, PhD (he/him/his) – Metrum Research Group ### 2360698###Speaker###Principal Scientist II###Metrum Research Group###Speaker: Timothy Waterhouse, PhD (he/him/his) – Metrum Research Group
### he/him/his @@@ Ralph Smith, PhD – North Carolina State University ### 2360699###Speaker###Distinguished University Professor, Professor of Mathematics###North Carolina State University###Speaker: Ralph Smith, PhD – North Carolina State University
### @@@ Nastya Kassir, PharmD, PhD, FCP (she/her/hers) – Genentech ### 2343528###Speaker###Senior Director & Distinguished Scientist###Genentech###Speaker: Nastya Kassir, PharmD, PhD, FCP (she/her/hers) – Genentech
### she/her/hersModerator: Joy C. Hsu, PhD – Genentech
### @@@ Sojeong Yi, PhD – FDA ### 2363740###Speaker###Clinical Pharmacology Reviewer###FDA###Speaker: Sojeong Yi, PhD – FDA
### @@@ Hao Zhu, PhD – ISoP ### 2360688###Panelist###ISoP Board Member###ISoP###Panelist: Hao Zhu, PhD – ISoP
###Speaker: Susana Zaph, PhD (she/her/hers) – Sanofi
### she/her/hersSpeaker: Xiaobin Li, M.S – GSK
###Speaker: Guobao Wang, PhD (he/him/his) – University of California, Davis
### he/him/hisSpeaker: Sean Hayes, PhD – Merck Research Laboratories
###Co-Chair: Sean McCann (he/him/his) – University of North Carolina
### he/him/his @@@ Yuhan Long, BS, BSChE (he/him/his) – University of Minnesota ### 2384750###Co-Chair###Graduate Student###University of Minnesota###Co-Chair: Yuhan Long, BS, BSChE (he/him/his) – University of Minnesota
### he/him/his @@@ Yanguang Cao, PhD (he/him/his) – University of North Carolina at Chapel Hill ### 2360726###Speaker###Associate Professor###University of North Carolina at Chapel Hill###Speaker: Yanguang Cao, PhD (he/him/his) – University of North Carolina at Chapel Hill
### he/him/his @@@ Xiaonan Li, PhD (she/her/hers) – Takeda Pharmaceuticals ### 2408459###Speaker###Sr. Clinical Pharmacologist###Takeda Pharmaceuticals###Speaker: Xiaonan Li, PhD (she/her/hers) – Takeda Pharmaceuticals
### she/her/hers @@@ Dongfen Yuan, PhD – Janssen Research & Development ### 2408458###Speaker###Associate Director###Janssen Research & Development###Speaker: Dongfen Yuan, PhD – Janssen Research & Development
###Speaker: Joga Gobburu, PhD MBA (he/him/his) – University of Maryland
### he/him/hisChair and Speaker: Monica Simeoni, PhD – Clinical Pharmacology Modelling and Simulation, Precision Medicine, GSK
### @@@ Phyllis Chan, PhD – Modeling & Simulation, Clinical Pharmacology, Genentech ### 2360712###Chair###Distinguished Scientist###Modeling & Simulation, Clinical Pharmacology, Genentech###Chair: Phyllis Chan, PhD – Modeling & Simulation, Clinical Pharmacology, Genentech
### @@@ Matthew L. Zierhut, PhD MBA (he/him/his) – Certara Drug Development Solutions ### 2360713###Speaker###VP###Certara Drug Development Solutions###Speaker: Matthew L. Zierhut, PhD MBA (he/him/his) – Certara Drug Development Solutions
### he/him/his @@@ Rana JREICH, PhD – Clinical Modeling, Clinical Modeling & Evidence Integration, Sanofi ### 2360714###Speaker###Associate Director###Clinical Modeling, Clinical Modeling & Evidence Integration, Sanofi###Speaker: Rana JREICH, PhD – Clinical Modeling, Clinical Modeling & Evidence Integration, Sanofi
### @@@ Elyes Dahmane, PhD – FDA ### 2360754###Speaker###Pharmacometrics Reviewer###FDA###Speaker: Elyes Dahmane, PhD – FDA
### @@@ Joseph Chen, PharmD – Genentech ### 2453821###Speaker###Senior Principal Scientist###Genentech###Speaker: Joseph Chen, PharmD – Genentech
###Chair: Matthew L. Fidler, M.Stat., PhD (he/him/his) – Novartis
### he/him/his @@@ William S Denney, Ph.D. (he/him/his) – Human Predictions ### 2360656###Speaker and Panelist###Chief Scientist###Human Predictions###Speaker and Panelist: William S Denney, Ph.D. (he/him/his) – Human Predictions
### he/him/his @@@ Mirjam Trame, Ph.D (she/her/hers) – Certara ### 2360657###Speaker and Panelist###Vice President Pharmacometrics###Certara###Speaker and Panelist: Mirjam Trame, Ph.D (she/her/hers) – Certara
### she/her/hers @@@ Justin J. Wilkins, PhD (he/him/his) – Occams ### 2360658###Speaker and Panelist###Owner and Senior Consultant at Occams, Fellow and past president of ISoP###Occams###Speaker and Panelist: Justin J. Wilkins, PhD (he/him/his) – Occams
### he/him/hisSpeaker: Eric Masson, PharmD – Arvinas
###Speaker: Youwei Bi, PhD – FDA, MD
### @@@ Da Zhang ### 2514036###Speaker#########Speaker: Da Zhang
###Speaker: Hao Zhu, PhD – ISoP
###Speaker: Xiling Jiang, PhD – US FDA
###Speaker: Robert R. Bies, Pharm.D. PhD FISoP – Department of Pharmaceutical Sciences, School of Pharmacy and Pharmaceutical Sciences, University at Buffalo
###Speaker: Hao-Jie Zhu, PhD – University of Michigan College of Pharmacy
###Speaker: Lixia Zhang, PhD – FDA
###Speaker: Brian Schmidt
###Speaker: Fulya Akpinar Singh, PhD (she/her/hers) – Genmab
### she/her/hersChair and Speaker: Joy C. Hsu, PhD – Genentech
### @@@ Hao Zhu, PhD – ISoP ### 2360688###Chair###ISoP Board Member###ISoP###Chair: Hao Zhu, PhD – ISoP
### @@@ Francesco Brizzi, PhD (he/him/his) – Predictive Modelling and Data Analytics, Roche Pharma Research & Early Development, Roche Innovation Center Basel, Switzerland ### 2360747###Speaker###Senior Scientist###Predictive Modelling and Data Analytics, Roche Pharma Research & Early Development, Roche Innovation Center Basel, Switzerland###Speaker: Francesco Brizzi, PhD (he/him/his) – Predictive Modelling and Data Analytics, Roche Pharma Research & Early Development, Roche Innovation Center Basel, Switzerland
### he/him/his @@@ Niklas Korsbo, Ph.D. (he/him/his) – DeepPumas, Pumas-AI Inc. ### 2343539###Speaker###Senior Product Engineer###DeepPumas, Pumas-AI Inc.###Speaker: Niklas Korsbo, Ph.D. (he/him/his) – DeepPumas, Pumas-AI Inc.
### he/him/hisSpeaker: Zackary R. Kenz, PhD – Simulations Plus
###Speaker: Wei Gao, PhD – Moderna
###Chair: Luke Fostvedt, PhD – Pfizer, Inc.
### @@@ Limei Cheng, PhD (she/her/hers) – Incyte Corporation ### 2481281###Chair###Sr Director, QSP Lead###Incyte Corporation###Chair: Limei Cheng, PhD (she/her/hers) – Incyte Corporation
### she/her/hers @@@ Hao Zhu, PhD – ISoP ### 2360688###Speaker###ISoP Board Member###ISoP###Speaker: Hao Zhu, PhD – ISoP
### @@@ Ioannis (Yannis) Androulakis, PhD – Rutgers University ### 2380007###Speaker###Professor###Rutgers University###Speaker: Ioannis (Yannis) Androulakis, PhD – Rutgers University
### @@@ Hao-Jie Zhu, PhD – University of Michigan College of Pharmacy ### 2408503###Speaker###Professor###University of Michigan College of Pharmacy###Speaker: Hao-Jie Zhu, PhD – University of Michigan College of Pharmacy
### @@@ Lourdes Cucurull-Sanchez, PhD MPhil (she/her/hers) – Pharmetheus ### 2380006###Panelist###Platform Scientific Lead###Pharmetheus###Panelist: Lourdes Cucurull-Sanchez, PhD MPhil (she/her/hers) – Pharmetheus
### she/her/hers @@@ Yuan Xiong, PhD – Johnson & Johnson ### 2380009###Panelist###Director###Johnson & Johnson###Panelist: Yuan Xiong, PhD – Johnson & Johnson
### @@@ Neelima Thanneer, MS – BMS ### 2360663###Panelist###Executive Director, Head of Data Science and Clin Pharm Analysis & Reporting###BMS###Panelist: Neelima Thanneer, MS – BMS
### @@@ Jiawei Zhou, PhD (she/her/hers) – Pfizer, Inc. ### 2360697###Panelist###Manager, Pharmacometrics & Systems Pharmacology###Pfizer, Inc.###Panelist: Jiawei Zhou, PhD (she/her/hers) – Pfizer, Inc.
### she/her/hersSpeaker: Yali Liang, MD – Jazz Pharmaceuticals
###